Rituxan Approved for Chronic Lymphocytic Leukemia (HealthDay) _health

Rituxan Approved for Chronic Lymphocytic Leukemia (HealthDay)

HealthDay - FRIDAY, Feb. 19 (HealthDay News) -- Rituxan (rituximab) has been approved by the U.S. Food and Drug Administration to treat a slowly progressing form of blood and bone marrow cancer known as chronic lymphocytic leukemia (CLL), the agency said in a press release.

Category：health
TAG：